{"entity":{"type":"insider","cik":"0001263165","url":"/insider/0001263165","json_url":"/insider/0001263165.json","name":"BENCHIMOL CLAUDE","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":3,"first":"2004-08-24","last":"2007-12-07","span_basis":"filed_date"},"name_variants":[{"name":"BENCHIMOL CLAUDE","source":"filing","n_filings":3,"first_seen":"2004-08-24","last_seen":"2007-12-07"}],"transactions":[{"id":7398894,"accession":"0001181431-07-074079","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-07-074079","line_url":"/filing/0001181431-07-074079#line-5","is_derivative":false,"issuer_cik":"0001073431","issuer_name":"INVITROGEN CORP","issuer_ticker":"IVGN","issuer_name_source":null,"issuer_url":"/issuer/0001073431","owner_cik":"0001263165","owner_name":"BENCHIMOL CLAUDE","owner_url":"/insider/0001263165","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":93196.0,"shares_display":"93,196","price_per_share":97.5,"price_display":"97.50","price_state":"stated","total_value":9086610.0,"total_display":"9,086,610.00","shares_owned_after":22482.0,"shares_owned_after_display":"22,482","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-06","filed_date":"2007-12-07","scope":"insider"},{"id":7398893,"accession":"0001181431-07-074079","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-07-074079","line_url":"/filing/0001181431-07-074079#line-4","is_derivative":false,"issuer_cik":"0001073431","issuer_name":"INVITROGEN CORP","issuer_ticker":"IVGN","issuer_name_source":null,"issuer_url":"/issuer/0001073431","owner_cik":"0001263165","owner_name":"BENCHIMOL CLAUDE","owner_url":"/insider/0001263165","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8032.0,"shares_display":"8,032","price_per_share":97.5,"price_display":"97.50","price_state":"stated","total_value":783120.0,"total_display":"783,120.00","shares_owned_after":7492.0,"shares_owned_after_display":"7,492","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-06","filed_date":"2007-12-07","scope":"insider"},{"id":7398891,"accession":"0001181431-07-074079","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-07-074079","line_url":"/filing/0001181431-07-074079#line-3","is_derivative":false,"issuer_cik":"0001073431","issuer_name":"INVITROGEN CORP","issuer_ticker":"IVGN","issuer_name_source":null,"issuer_url":"/issuer/0001073431","owner_cik":"0001263165","owner_name":"BENCHIMOL CLAUDE","owner_url":"/insider/0001263165","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5352.0,"shares_display":"5,352","price_per_share":97.4,"price_display":"97.40","price_state":"stated","total_value":521284.8,"total_display":"521,284.80","shares_owned_after":15524.0,"shares_owned_after_display":"15,524","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-06","filed_date":"2007-12-07","scope":"insider"},{"id":7398890,"accession":"0001181431-07-074079","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-07-074079","line_url":"/filing/0001181431-07-074079#line-2","is_derivative":false,"issuer_cik":"0001073431","issuer_name":"INVITROGEN CORP","issuer_ticker":"IVGN","issuer_name_source":null,"issuer_url":"/issuer/0001073431","owner_cik":"0001263165","owner_name":"BENCHIMOL CLAUDE","owner_url":"/insider/0001263165","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1606.0,"shares_display":"1,606","price_per_share":97.5,"price_display":"97.50","price_state":"stated","total_value":156585.0,"total_display":"156,585.00","shares_owned_after":20876.0,"shares_owned_after_display":"20,876","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-06","filed_date":"2007-12-07","scope":"insider"},{"id":7320619,"accession":"0001181431-07-073164","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-07-073164","line_url":"/filing/0001181431-07-073164#line-1","is_derivative":false,"issuer_cik":"0001073431","issuer_name":"INVITROGEN CORP","issuer_ticker":"IVGN","issuer_name_source":null,"issuer_url":"/issuer/0001073431","owner_cik":"0001263165","owner_name":"BENCHIMOL CLAUDE","owner_url":"/insider/0001263165","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1031.0,"shares_display":"1,031","price_per_share":91.4,"price_display":"91.40","price_state":"stated","total_value":94233.4,"total_display":"94,233.40","shares_owned_after":22482.0,"shares_owned_after_display":"22,482","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-19","filed_date":"2007-12-04","scope":"insider"},{"id":415979,"accession":"0001263165-04-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001263165-04-000004","line_url":"/filing/0001263165-04-000004#line-2","is_derivative":false,"issuer_cik":"0001073431","issuer_name":"INVITROGEN CORP","issuer_ticker":"IVGN","issuer_name_source":null,"issuer_url":"/issuer/0001073431","owner_cik":"0001263165","owner_name":"BENCHIMOL CLAUDE","owner_url":"/insider/0001263165","role":"Officer (SVP R&D (CTO)","officer_title":"SVP R&D (CTO)","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":50.7,"price_display":"50.70","price_state":"stated","total_value":25350.0,"total_display":"25,350.00","shares_owned_after":25590.0,"shares_owned_after_display":"25,590","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-08-20","filed_date":"2004-08-24","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001073431","name":"INVITROGEN CORP","url":"/issuer/0001073431","role":"Officer (SVP, Research & Development)","n_filings":3,"first_seen":"2004-08-24","last_seen":"2007-12-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001263165","retrieved_at":"2026-08-21T19:24:41+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}